✦ LIBER ✦

Interleukin-6: A Potential Biomarker of Resistance to Multitargeted Receptor Tyrosine Kinase Inhibitors in Castration-resistant Prostate Cancer

✍ Scribed by Alexander Kutikov; Peter Makhov; Konstantin Golovine; Daniel J. Canter; Mohit Sirohi; Ryan Street; Jay Simhan; Robert G. Uzzo; Vladimir M. Kolenko

Book ID: 118502898
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 702 KB
Volume: 78
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2011.07.1384

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

408 INTERLEUKIN-6: A POTENTIAL BIOMARKER

408 INTERLEUKIN-6: A POTENTIAL BIOMARKER OF RESISTANCE TO MULTITARGETED RECEPTOR TYROSINE KINASE INHIBITORS IN CASTRATION-RESISTANT PROSTATE CANCER

✍ Kutikov, Alexander; Makhov, Peter; Golovine, Konstantin; Canter, Daniel; Sirohi, 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 42 KB

Overexpression of the potential kinase s

Overexpression of the potential kinase serine/ threonine/tyrosine kinase 1 (STYK 1) in castration-resistant prostate cancer

✍ Suyoun Chung; Kenji Tamura; Mutsuo Furihata; Motohide Uemura; Yataro Daigo; Yasu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB

150 Autophagy is a Survival Mechanism Me

150 Autophagy is a Survival Mechanism Mediating Resistance to Androgen Receptor Signaling Inhibitors in Castrate Resistant Prostate Cancer Cells

✍ Nguyen, H.; Yang, J.; Kung, H.J.; Gao, A.; Evans, C. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

420 IN VIVO CASTRATION-RESISTANT ACCELER

420 IN VIVO CASTRATION-RESISTANT ACCELERATION OF PROSTATE CANCER INHIBITED BY A SMALL MOLECULE INHIBITOR OF INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR/INSULIN RECEPTOR TYROSINE KINASE

✍ Inoue, Takamitsu; Zakikhani, Mahvash; Mireuta, Matei; Blouin, Marie-José; Pollak 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 134 KB

503 AUTOPHAGY IS A SURVIVAL MECHANISM IN

503 AUTOPHAGY IS A SURVIVAL MECHANISM IN MEDIATING RESISTANCE TO ANDROGENT RECEPTOR SIGNALING INHIBITORS IN CASTRATE RESISTANT PROSTATE CANCER CELLS

✍ Nguyen, Hao G.; Yang, Joy C.; Hsing-Jien, Kung; Gao, Allen C.; Evans, Christophe 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 49 KB

A phase II study of lapatinib, a dual EG

A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancer

✍ Whang, Young E.; Armstrong, Andrew J.; Rathmell, W. Kimryn; Godley, Paul A.; Kim 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 220 KB